Mini Focus Issue: Heart Failure With Preserved Ejection FractionState-of-the-Art PaperDeveloping Therapies for Heart Failure With Preserved Ejection Fraction: Current State and Future Directions
Key Words
Abbreviations and Acronyms
Cited by (0)
The opinions and information in this article are those of the authors, and do not represent the views and/or policies of the U.S. Food and Drug Administration. Dr. Fonarow has served as a consultant for Novartis, Medtronic, and Gambro, and has received research support from Gambro, the National Institutes of Health, and the Agency for Healthcare Research and Quality. Dr. Zile has received research support from NHLBI, VA, Alere, Bayer, CVRx, Medtronic, Novartis, Sanofi-Aventis; and has served as a consultant for Abbott, Alere, Bayer, BG Med, BMS, Cardiome, Celledon, CorAssist, CVRx, GE Health, HDL, Idenex, Intersection Medical, Medtronic, MicroVide, Novartis, ONO Pharma, Sanofi-Aventis, and Up-To-Date. Dr. Lam has served as a consultant for Bayer and Novartis and has received research grant support from Boston Scientific, Medtronic, and Vifor Pharma. Dr. Roessig is an employee of Bayer Pharma. Dr. Schelbert received a Prohance contrast as a gift from Bracco for research purposes. Dr. Cleland has received research funding from Amgen and honoraria from Novartis. Dr. Cody is an employee of Janssen R&D. Dr. Collins has served as a consultant for Novartis, Radiometer, Medtronic, The Medicines Company, Trevena, and Thermo-Fisher Scientific. Dr. Filippatos has served on the steering committee in trials sponsored by Bayer and Corthera. Dr. Lefkowitz is an employee of Novartis. Dr. McMurray was a committee member and co-principal investigator for the PARAGON-HF trial with LCZ696 in HF-PEF, which was sponsored by Novartis. Dr. Misselwitz is an employee of and owns stock for Bayer. Dr. Pfeffer has served as a consultant for Aastrom, Amgen, Bristol-Myers-Squibb, Cerenis, Concert, Genzyme, Hamilton Health Sciences, Keryx, Medtronic, Merck, Novartis, Roche, Servier, Teva, the University of Oxford, and Xoma. Dr. Pieske has received honoraria from Bayer, Servier, Medtronic, Menarini, Daiichi-Sankyo, and Boehringer Ingelheim. Dr. Pitt has served as a consultant for Pfizer, Bayer, Relypsa, Stealth Peptides, and Mesoblast. Dr. Solomon has received research support from and has served as a consultant for Novartis and Bayer. Dr. Teerlink has received research support and consulting fees from Novartis. Dr. Gheorghiade has served as a consultant for Novartis, Bayer, Takeda, and Janssen. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.